Skip to content

Boxer Capital Management, LLC

Follow

13F filer, CIK 2018299, San Diego, CA

Boxer Capital Management, LLC reported $1,150,652,180 across 47 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 71.39% of the portfolio.

Accepted , ingested 13F-HR 0001213900-26-120704

Period
2026-09-30
Reported value
$1.15B
Holdings
47
Top 10 weight
71.39%
New
12
Sold out
28

Part of the filer group Boxer Capital Management, LLC

  • Aaron Davis
  • Boxer Holdings GP, LLC
  • Boxer Holdings, LP
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ACHVnew+2,150,000$17.4M
SYREadded+183,054$16.3M
CCCCnew+4,150,000$13.8M
KYMRadded+95,451$10.7M
TRAXnew+240,000$8.51M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VIRexited-1,866,000-$19M
PCVXexited-325,000-$18.9M
CRVSexited-1,100,000-$16.4M
PTCTexited-200,000-$16.3M
PRAXexited-46,457-$15.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001213900-26-120704, largest first. % of portfolio is the value over $1,150,652,180, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,380,999 shares; 2025Q1: 10,380,999 shares; 2025Q2: 9,771,485 shares; 2025Q3: 9,771,485 shares; 2025Q4: 10,876,219 shares; 2026Q1: 10,876,219 shares; 2026Q2: 10,876,219 shares; 2026Q3: 10,526,219 shares 10,526,219$263M22.82%-350,000Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,035,000 shares; 2025Q2: 750,000 shares; 2025Q3: 750,000 shares; 2025Q4: 1,136,000 shares; 2026Q1: 1,361,000 shares; 2026Q2: 1,477,600 shares; 2026Q3: 1,477,600 shares 1,477,600$140M12.17%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,279,464 shares; 2025Q1: 1,317,977 shares; 2025Q2: 792,977 shares; 2025Q3: 400,000 shares; 2025Q4: 400,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$103M8.92%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 425,000 shares; 2025Q1: 325,000 shares; 2025Q2: 432,010 shares; 2025Q3: 319,100 shares; 2025Q4: 329,100 shares; 2026Q1: 329,100 shares; 2026Q2: 429,100 shares; 2026Q3: 524,551 shares 524,551$58.6M5.1%+95,451Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,796,341 shares; 2025Q1: 1,796,341 shares; 2025Q2: 2,211,341 shares; 2025Q3: 1,050,000 shares; 2025Q4: 750,000 shares; 2026Q1: 1,175,000 shares; 2026Q2: 3,983,000 shares; 2026Q3: 4,278,159 shares 4,278,159$56.6M4.92%+295,159Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 120,000 shares; 2025Q4: 125,000 shares; 2026Q1: 200,000 shares; 2026Q2: 605,000 shares; 2026Q3: 474,971 shares 474,971$47M4.09%-130,029Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 416,150 shares; 2026Q1: 766,318 shares; 2026Q2: 1,105,683 shares; 2026Q3: 1,360,683 shares 1,360,683$43.8M3.81%+255,000Timeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 250,000 shares; 2026Q2: 335,500 shares; 2026Q3: 335,500 shares 335,500$38.7M3.36%0Timeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 850,000 shares; 2025Q4: 1,375,000 shares; 2026Q1: 3,500,000 shares; 2026Q2: 5,150,000 shares; 2026Q3: 4,320,339 shares 4,320,339$37M3.21%-829,661Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: 750,000 shares; 2025Q2: 899,500 shares; 2025Q3: 800,000 shares; 2025Q4: 290,000 shares; 2026Q1: 662,000 shares; 2026Q2: 1,503,300 shares; 2026Q3: 1,423,243 shares 1,423,243$34.4M2.99%-80,057Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 598,500 shares; 2026Q2: 998,500 shares; 2026Q3: 683,615 shares 683,615$26M2.26%-314,885Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,750,000 shares; 2025Q1: 1,750,000 shares; 2025Q2: 1,225,000 shares; 2025Q3: 900,000 shares; 2025Q4: 800,000 shares; 2026Q1: 800,000 shares; 2026Q2: 800,000 shares; 2026Q3: 893,153 shares 893,153$26M2.26%+93,153Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 466,680 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 283,054 shares 283,054$25.2M2.19%+183,054Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,000 shares; 2025Q3: 110,000 shares; 2025Q4: 170,000 shares; 2026Q1: 170,000 shares; 2026Q2: 170,000 shares; 2026Q3: 170,000 shares 170,000$24M2.08%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 90,000 shares; 2025Q4: 225,000 shares; 2026Q1: 225,000 shares; 2026Q2: 416,530 shares; 2026Q3: 286,239 shares 286,239$22.8M1.98%-130,291Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,250,000 shares; 2026Q2: 2,815,000 shares; 2026Q3: 4,533,660 shares 4,533,660$21.9M1.91%+1,718,660Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,149,310 shares; 2026Q3: 2,577,642 shares 2,577,642$21.3M1.85%-571,668Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 575,000 shares; 2025Q3: 575,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$20.3M1.77%0Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,150,000 shares 2,150,000$17.4M1.51%newTimeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,150,000 shares 4,150,000$13.8M1.2%newTimeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 240,000 shares 240,000$8.51M0.74%newTimeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares; 2026Q3: 1,175,396 shares 1,175,396$8.02M0.7%+175,396Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,500,000 shares 2,500,000$7.92M0.69%newTimeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 907,895 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$6.91M0.6%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 494,000 shares; 2026Q1: 494,000 shares; 2026Q2: 494,000 shares; 2026Q3: 494,000 shares 494,000$6.63M0.58%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$6.59M0.57%0Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,799,875 shares; 2026Q1: 4,799,875 shares; 2026Q2: 4,799,875 shares; 2026Q3: 4,799,875 shares 4,799,875$6.48M0.56%0Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 325,000 shares; 2026Q1: 590,000 shares; 2026Q2: 1,395,156 shares; 2026Q3: 642,837 shares 642,837$6.09M0.53%-752,319Timeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$5.06M0.44%newTimeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 749,035 shares; 2026Q2: 749,035 shares; 2026Q3: 944,035 shares 944,035$5.02M0.44%+195,000Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175,465 shares 175,465$4.77M0.41%newTimeline
EDSAEDESA BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 205,000 shares; 2026Q3: 937,363 shares 937,363$3.95M0.34%+732,363Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 536,132 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 450,000 shares; 2026Q3: 200,000 shares 200,000$3.61M0.31%-250,000Timeline
KZIAKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 560,000 shares; 2026Q3: 371,500 shares 371,500$3.56M0.31%-188,500Timeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000$3.43M0.3%newTimeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,050,000 shares 2,050,000$3.42M0.3%newTimeline
CRESCENT BIOPHARMA INC.CRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 453,686 shares; 2026Q2: 453,686 shares; 2026Q3: 226,843 shares 226,843$3.31M0.29%-226,843
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 450,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,013,555 shares 1,013,555$2.81M0.24%newTimeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,000 shares; 2025Q3: 250,000 shares; 2025Q4: 150,000 shares; 2026Q1: 150,000 shares; 2026Q2: 150,000 shares; 2026Q3: 150,000 shares 150,000$2.73M0.24%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,725,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,500,000 shares 1,500,000$2.4M0.21%0Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 563,067 shares; 2025Q1: 563,067 shares; 2025Q2: 175,000 shares; 2025Q3: 175,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$2.37M0.21%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 391,723 shares 391,723$2.06M0.18%newTimeline
CLNNCLENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 199,737 shares; 2026Q1: 477,515 shares; 2026Q2: 477,515 shares; 2026Q3: 477,515 shares 477,515$1.95M0.17%0Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$1.58M0.14%newTimeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 309,007 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 666,666 shares; 2025Q4: 666,666 shares; 2026Q1: 666,666 shares; 2026Q2: 666,666 shares; 2026Q3: 666,666 shares 666,666$577K0.05%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,000,000 shares; 2026Q3: 954,052 shares 954,052$569K0.05%-1,045,948Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 252,536 shares; 2026Q1: 302,536 shares; 2026Q2: 302,536 shares; 2026Q3: 127,536 shares 127,536$156K0.01%-175,000Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VIRVIR BIOTECHNOLOGY INC1,866,000$19Mshares
PCVXVAXCYTE INC325,000$18.9Mshares
CRVSCORVUS PHARMACEUTICALS INC1,100,000$16.4Mshares
PTCTPTC THERAPEUTICS INC200,000$16.3Mshares
PRAXPRAXIS PRECISION MEDICINES I46,457$15.6Mshares
OCULOCULAR THERAPEUTIX INC1,300,000$12.8Mshares
APGEAPOGEE THERAPEUTICS INC70,000$9.29Mshares
COGTCOGENT BIOSCIENCES INC225,000$8.71Mshares
AVTXAVALO THERAPEUTICS INC375,000$6.93Mshares
FBRXFORTE BIOSCIENCES INC274,500$5.83Mshares
RLMDRELMADA THERAPEUTICS INC842,106$5.83Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS275,000$5.35Mshares
ZURAZURA BIO LTD900,000$5.31Mshares
HELPCYBIN INC790,000$5.22Mshares
ODTXODYSSEY THERAPEUTICS INC275,000$5.15Mshares
IMTXIMMATICS N.V475,000$4.81Mshares
FTHFAETH THERAPEUTICS INC180,505$4.51Mshares
GPCRSTRUCTURE THERAPEUTICS INC75,000$4.03Mshares
ORICORIC PHARMACEUTICALS INC350,000$3.79Mshares
INOINOVIO PHARMACEUTICALS INC2,844,994$3.13Mshares
SLDBSOLID BIOSCIENCES INC300,000$3Mshares
MPLTMAPLIGHT THERAPEUTICS INC75,000$2.69Mshares
LBRXLB PHARMACEUTICALS INC70,000$2.27Mshares
IVVDINVIVYD INC1,500,000$1.31Mshares
UPBUPSTREAM BIO INC150,000$1.04Mshares
PEPGPEPGEN INC272,892$491Kshares
RGNXREGENXBIO INC15,000$180Kshares
SRZNWSURROZEN INC66,666$1.07Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-26-120704 base2026-11-16